Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

From CC,

R & D day is going to be 10-11-18.

They will give full details about M254 and what the second disease, that has no known treatment is going to be for the clinical trial. They know what the disease is but will not disclose it until approved for the clinical trial.

I am guessing it is taking longer because of the second disease being discussed as there is no known TX and likely the FDA wants to make sure of the clinical trial criteria. I am hoping it is a disease that has big potential.

The main hit was the 30M they were required to pay for M923 product. There a but for clause, we don't have to buy, would have been nice. Might want to make sure that is in future contracts.

M281 on track.

Boing X 2